HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Subcortical dementia — Clinical Guidelines

Overview

Subcortical dementia encompasses a range of neurological disorders characterized by cognitive decline primarily affecting subcortical brain structures, often linked to vascular pathology, small vessel disease, and conditions like subcortical arteriosclerotic encephalopathy (Binswanger's disease). 1 14 15

Diagnosis

Key Diagnostic Criteria: Cognitive impairment, often with focal neurological signs; MRI/CT showing white matter hyperintensities, periventricular hypodensities, and lacunes. 1 10 14

Recommended Tests:

- MRI/CT Scans: Visual rating scales for subcortical cerebrovascular disease can help identify mild clinical symptoms. 6 - Vessel Wall Imaging: Useful in differentiating etiologies of subcortical infarction, particularly identifying dilated lenticulostriate arteries. 1 - OCT: Assesses retinal neurodegeneration in subcortical infarction patients. 2 - 1H-MRS: Differentiates white matter hyperintensities in SAE from those in normal elderly. 7 - EEG: Periodic EEG activity may indicate subcortical arteriosclerotic encephalopathy, especially in presence of dementia and hypertension. 16

Management

First-Line Treatments:

- Blood Pressure Control: Essential in managing hypertension-related subcortical arteriosclerotic encephalopathy. 14 15 - Enzymatic Blood Defibrination: Ancrod to reduce plasma fibrinogen and hyperviscosity in SAE. 11

Adjunctive Treatments:

- Cortical Stimulation: Sensory-parietal cortical stimulation may promote motor recovery in severe capsular infarcts. 3 - Rehabilitation: Conventional rehabilitative interventions, though responses vary among elderly patients. 3

Special Populations

Elderly: Increased prevalence of subcortical white matter strokes; management focuses on blood pressure control and rehabilitation. 3 14

Comorbidities: Hypertension significantly influences the diagnosis and management of subcortical arteriosclerotic encephalopathy. 14 15 17

Key Recommendations

Utilize MRI/CT with visual rating scales for early detection of subcortical cerebrovascular disease (Evidence: Moderate 6).

Control hypertension rigorously to mitigate progression of subcortical arteriosclerotic encephalopathy (Evidence: Moderate 14 15).

Consider sensory-parietal cortical stimulation as an adjunctive therapy for motor recovery in severe subcortical infarcts (Evidence: Weak 3).

Monitor and manage plasma hyperviscosity in SAE patients through enzymatic treatments like ancrod (Evidence: Weak 11).

Include periodic EEG monitoring in patients with dementia, hypertension, and focal neurological signs to identify subcortical arteriosclerotic encephalopathy (Evidence: Moderate 16).

References

1 Li J, Niu J, Zheng W, Bian Y, Wu F, Jia X et al.. Dilated lenticulostriate artery on whole-brain vessel wall imaging differentiates pathogenesis and predicts clinical outcomes in single subcortical infarction. European radiology 2025. link 2 Pan R, Ye C, Zhang Z, Kwapong WR, Wang R, Lu K et al.. Distinct alterations of retinal structure between thalamic and extra-thalamic subcortical infarction patients: A cross-sectional and longitudinal study. CNS neuroscience & therapeutics 2024. link 3 Kim RG, Cho J, Ree J, Kim HS, Rosa-Neto P, Kim JM et al.. Sensory-parietal cortical stimulation improves motor recovery in severe capsular infarct. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2016. link 4 Maeshima S, Osawa A, Yamane F, Yoshihara T, Kanazawa R, Ishihara S. Retrosplenial amnesia without topographic disorientation caused by a lesion in the nondominant hemisphere. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2014. link 5 Hallevi H, Chernyshev OY, El Khoury R, Soileau MJ, Walker KC, Grotta JC et al.. Intracranial atherosclerosis is associated with progression of neurological deficit in subcortical stroke. Cerebrovascular diseases (Basel, Switzerland) 2012. link 6 Geroldi C, Galluzzi S, Miao J, Testa C, Frisoni GB. Development of a CT-based weighted rating scale for subcortical cerebrovascular disease sensitive to mild clinical symptoms. Journal of the neurological sciences 2002. link00298-8) 7 Brooks WM, Wesley MH, Kodituwakku PW, Garry PJ, Rosenberg GA. 1H-MRS differentiates white matter hyperintensities in subcortical arteriosclerotic encephalopathy from those in normal elderly. Stroke 1997. link 8 Fukui T, Hasegawa Y, Seriyama S, Takeuchi T, Sugita K, Tsukagoshi H. Hemiballism-hemichorea induced by subcortical ischemia. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1993. link 9 Révész T, Hawkins CP, du Boulay EP, Barnard RO, McDonald WI. Pathological findings correlated with magnetic resonance imaging in subcortical arteriosclerotic encephalopathy (Binswanger's disease). Journal of neurology, neurosurgery, and psychiatry 1989. link 10 Weisberg LA, Gerard G, Stazio A. Computerized tomographic findings and differential diagnostic considerations in subcortical arteriosclerotic encephalopathy (Binswanger's disease). Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society 1988. link90008-x) 11 Ringelstein EB, Mauckner A, Schneider R, Sturm W, Doering W, Wolf S et al.. Effects of enzymatic blood defibrination in subcortical arteriosclerotic encephalopathy. Journal of neurology, neurosurgery, and psychiatry 1988. link 12 Alexander MP, Naeser MA, Palumbo CL. Correlations of subcortical CT lesion sites and aphasia profiles. Brain : a journal of neurology 1987. link 13 Benhaïem-Sigaux N, Gray F, Gherardi R, Roucayrol AM, Poirier J. Expanding cerebellar lacunes due to dilatation of the perivascular space associated with Binswanger's subcortical arteriosclerotic encephalopathy. Stroke 1987. link 14 Kinkel WR, Jacobs L, Polachini I, Bates V, Heffner RR. Subcortical arteriosclerotic encephalopathy (Binswanger's disease). Computed tomographic, nuclear magnetic resonance, and clinical correlations. Archives of neurology 1985. link 15 Loizou LA, Kendall BE, Marshall J. Subcortical arteriosclerotic encephalopathy: a clinical and radiological investigation. Journal of neurology, neurosurgery, and psychiatry 1981. link 16 White JC. Periodic EEG activity in subcortical arteriosclerotic encephalopathy (Binswanger's type). Archives of neurology 1979. link 17 Maeda S, Nakayama H, Isaka K, Aihara Y, Nemoto S. Familial unusual encephalopathy of Binswanger's type without hypertension. Folia psychiatrica et neurologica japonica 1976. link

Subcortical dementia